Shanghai Yizhong Pharmaceutical Co. Ltd. Class ASSE: 688091

Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for the Investigational New Drug YXC-002

· Issued by Shanghai Yizhong Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure on the Acceptance of the Clinical Trial Application for the Investigational New Drug YXC-002

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis